Skip to main content
Clinical Trials/NCT02285725
NCT02285725
Completed
Not Applicable

Microdrilling Surgery for Full Thickness Chondral Lesions of the Knee Augmented With Concentrated Bone Marrow Aspirate, Platelet Rich Plasma and Hyaluronic Acid

Joseph E. Broyles0 sites21 target enrollmentMarch 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Unilateral Primary Osteoarthritis of Knee
Sponsor
Joseph E. Broyles
Enrollment
21
Primary Endpoint
Change in International Knee Documentation Committee (IKDC) score
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study seeks to evaluate a treatment for multiple full thickness chondral lesions in the knee. Eligible subjects will undergo a microdrilling surgery and up to 12 post operative intra-articular injections of bone marrow aspirate concentrate (BMAC), platelet rich plasma (PRP) and hyaluronic acid (HA).

Registry
clinicaltrials.gov
Start Date
March 2011
End Date
February 15, 2019
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Joseph E. Broyles
Responsible Party
Sponsor Investigator
Principal Investigator

Joseph E. Broyles

Joseph E. Broyles, M.D.

Bone and Joint Clinic of Baton Rouge

Eligibility Criteria

Inclusion Criteria

  • MRI-confirmed full-thickness unipolar or bipolar chondral lesion(s) from osteoarthritis.

Exclusion Criteria

  • Inflammatory arthritis
  • Body mass index (BMI) greater than 35
  • Presence of significant varus or valgus knee instability or unusually stiff knee
  • Greater than 50% deviation of the mechanical axis
  • Presence of active cardiac disease
  • Presence of active pulmonary disease
  • Prior septic arthritis of the involved joint
  • Presence of active bacterial or Mycobacterial infection
  • Presence of a known hypercoagulable state
  • Pregnant or lactating females

Outcomes

Primary Outcomes

Change in International Knee Documentation Committee (IKDC) score

Time Frame: Change from baseline at 5 years post-operatively

Secondary Outcomes

  • MRI appearance of repair cartilage(2 and 5 years post-operatively)
  • Joint Space Changes(2 and 5 years post-operatively)
  • Frequency of adverse events requiring additional procedures(Continuously for 5 years post-operatively)

Similar Trials